Cargando…
RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis
Receptor interacting protein kinase 1 (RIPK1) mediates cell death and inflammatory signaling and is increased in multiple sclerosis (MS) brain samples. Here, we investigate the role of glial RIPK1 kinase activity in mediating MS pathogenesis. We demonstrate RIPK1 levels correlate with MS disease pro...
Autores principales: | Zelic, Matija, Pontarelli, Fabrizio, Woodworth, Lisa, Zhu, Cheng, Mahan, Amy, Ren, Yi, LaMorte, Michael, Gruber, Ross, Keane, Aislinn, Loring, Pequita, Guo, Lilu, Xia, Tai-he, Zhang, Boyao, Orning, Pontus, Lien, Egil, Degterev, Alexei, Hammond, Timothy, Ofengeim, Dimitry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917516/ https://www.ncbi.nlm.nih.gov/pubmed/33979622 http://dx.doi.org/10.1016/j.celrep.2021.109112 |
Ejemplares similares
-
Targeting RIPK1 for the treatment of human diseases
por: Degterev, Alexei, et al.
Publicado: (2019) -
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
por: Mifflin, Lauren, et al.
Publicado: (2020) -
Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration
por: Ryan, Sean K., et al.
Publicado: (2022) -
Targeting RIPK1,2,3 to combat inflammation
por: Bullock, Alex N., et al.
Publicado: (2015) -
Gasdermins and their role in immunity and inflammation
por: Orning, Pontus, et al.
Publicado: (2019)